(CIDRAP News) Saying current treatment practices vary widely, the Infectious Diseases Society of America (IDSA) today released lengthy guidelines for treating methicillin-resistant Staphylococcus aureus (MRSA) infections, which the group said now account for most of the skin infections that send people to emergency rooms.
(CIDRAP News) Obesity as a risk factor for severe illness and death was one of the clinical surprises that emerged early in the 2009 H1N1 pandemic, and now California researchers have shown that extreme obesity is an independent risk factor for death from the disease.
(CIDRAP News) Two federal officials who frequently appeared on television as top sources during the 2009 H1N1 pandemic provided a rare glimpse behind the curtain at some of the event's pivotal moments today during a panel discussion at an infectious disease conference in Washington, DC.
(CIDRAP News) Although antiviral drugs were used to treat many seriously sick people during the H1N1 influenza pandemic, experts at a conference today said they could have been used more widely and that some opportunities to learn from their use were missed.
(CIDRAP News) Federal health officials today released a lengthy set of new guidelines for preventing bloodstream infections in patients with intravenous catheters, a problem that's estimated to cost the nation billions of dollars a year.
(CIDRAP News) Warning that medical procedures such as surgery and chemotherapy will become impossible if current trends continue, the Infectious Diseases Society of America (IDSA) today called for a many-pronged campaign to counter the ever-growing threat of antimicrobial resistance.
(CIDRAP News) Sanofi Pasteur's intradermal influenza vaccine, which involves a shallow needle prick into the skin instead of deep into muscle tissue, has been approved by the US Food and Drug Administration (FDA), the company announced today.